Verrica Pharmaceuticals Inc (VRCA)
0.8732
+0.03
(+3.58%)
USD |
NASDAQ |
Nov 14, 16:00
0.8732
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 205.07 |
| June 27, 2024 | 203.10 |
| June 26, 2024 | 198.32 |
| June 25, 2024 | 198.04 |
| June 24, 2024 | 200.00 |
| June 21, 2024 | 209.57 |
| June 20, 2024 | 202.82 |
| June 18, 2024 | 225.04 |
| June 17, 2024 | 229.54 |
| June 14, 2024 | 228.42 |
| June 13, 2024 | 240.79 |
| June 12, 2024 | 241.36 |
| June 11, 2024 | 251.20 |
| June 10, 2024 | 240.79 |
| June 07, 2024 | 230.10 |
| June 06, 2024 | 246.98 |
| June 05, 2024 | 257.39 |
| June 04, 2024 | 233.76 |
| June 03, 2024 | 241.36 |
| May 31, 2024 | 239.39 |
| May 30, 2024 | 234.32 |
| May 29, 2024 | 237.14 |
| May 28, 2024 | 236.85 |
| May 24, 2024 | 240.79 |
| May 23, 2024 | 234.89 |
| Date | Value |
|---|---|
| May 22, 2024 | 254.58 |
| May 21, 2024 | 246.70 |
| May 20, 2024 | 244.73 |
| May 17, 2024 | 243.89 |
| May 16, 2024 | 257.39 |
| May 15, 2024 | 255.98 |
| May 14, 2024 | 266.95 |
| May 13, 2024 | 268.92 |
| May 10, 2024 | 225.04 |
| May 09, 2024 | 220.54 |
| May 08, 2024 | 214.07 |
| May 07, 2024 | 215.19 |
| May 06, 2024 | 205.63 |
| May 03, 2024 | 204.22 |
| May 02, 2024 | 190.16 |
| May 01, 2024 | 192.69 |
| April 30, 2024 | 195.93 |
| April 29, 2024 | 201.13 |
| April 26, 2024 | 193.25 |
| April 25, 2024 | 187.06 |
| April 24, 2024 | 191.00 |
| April 23, 2024 | 192.69 |
| April 22, 2024 | 191.00 |
| April 19, 2024 | 196.35 |
| April 18, 2024 | 194.10 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.919
Minimum
Nov 09 2022
268.92
Maximum
May 13 2024
17.47
Average
5.809
Median
Nov 11 2020
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.309 |
| Elite Pharmaceuticals Inc | 9.494 |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | 26.31 |
| Terns Pharmaceuticals Inc | 2.109 |
Price to Book Value Related Metrics
| PS Ratio | 4.411 |
| PEG Ratio | -0.0066 |
| Price | 0.8732 |
| Earnings Yield | -210.7% |
| Market Cap | 39.82M |
| PEGY Ratio | -0.0066 |